Embryonal rhabdomyosarcoma as a second malignancy following multimodal therapy for advanced-stage neuroblastoma

被引：3

作者：

Mann, Gurdeep S.

Byrne, Angela T. ^{[1
]}

Nadel, Helen R. ^{[1
]}

Bray, Heather

机构：

[1] British Columbia Childrens Hosp, Dept Radiol, Div Nucl Med, Vancouver, BC V6H 3V4, Canada

来源：

PEDIATRIC RADIOLOGY | 2008年 / 38卷 / 09期

关键词：

PET/CT; oncology; sarcoma; child; rhabdomyosarcoma; neuroblastoma;

D O I：

10.1007/s00247-008-0905-y

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Second malignancy as a long-term complication in survivors of advanced-stage neuroblastoma is rare, but it is becoming recognized more frequently. We report an unusual case of a soft-tissue sarcoma developing within a retroperitoneal primary following previous extensive treatment for metastatic neuroblastoma using multimodality imaging including PET/CT.

引用

页码：1017 / 1020

页数：4

共 50 条

[21] Drug Therapy for Advanced-Stage Liver Cancer
Peck-Radosavljevic, Markus
LIVER CANCER, 2014, 3 (02) : 125 - 131
[22] Management of advanced-stage neuroblastoma in a patient with 21-hydroxalase deficiency
Utsunomiya, Akari N.
Okada, Satoshi
Hara, Keiichi
Miki, Mizuka
Mizoguchi, Yoko
Kobayashi, Yoshiyuki
Miyagawa, Shinichiro
Jinno, Kazuhiko
Nakamura, Kazuhiro
Sato, Takashi
Kobayashi, Masao
PEDIATRICS INTERNATIONAL, 2013, 55 (04) : E96 - E99
[23] POOR OUTCOME IN PATIENTS WITH ADVANCED-STAGE NEUROBLASTOMA AND COINCIDENT OPSOMYOCLONUS SYNDROME
HIYAMA, E
YOKOYAMA, T
ICHIKAWA, T
HIYAMA, K
KOBAYASHI, M
TANAKA, Y
UEDA, K
TANAKA, Y
YANO, H
CANCER, 1994, 74 (06) : 1821 - 1826
[24] Oropharyngeal cancer with advanced-stage regional metastasis: Outcomes following primary chemoradiation therapy
Moukarbel, R. V.
Venkatesan, V.
Pavamani, S.
Hammond, A.
Read, N.
Franklin, J. H.
ORAL ONCOLOGY, 2009, : 95 - 95
[25] Progress in systemic therapy for advanced-stage urothelial carcinoma
Nadal, Rosa
Valderrama, Begona P.
Bellmunt, Joaquim
NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (01) : 8 - 27
[26] Progress in systemic therapy for advanced-stage urothelial carcinoma
Rosa Nadal
Begoña P. Valderrama
Joaquim Bellmunt
Nature Reviews Clinical Oncology, 2024, 21 : 8 - 27
[27] Evolution of systemic therapy for advanced-stage hepatocellular carcinoma
Hur, Moon Haeng
Kim, Yoon Jun
HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (06) : 899 - 902
[28] Organ preservation therapy for advanced-stage laryngeal carcinoma
Hoffman, HT
McCulloch, T
Gustin, D
Karnell, LH
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1997, 30 (01) : 113 - +
[29] MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN
Cohn, SL
London, WB
Huang, DH
Katzenstein, HM
Salwen, HR
Reinhart, T
Madafiglio, J
Marshall, GM
Norris, MD
Haber, M
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 3604 - 3613
[30] FIRST LINE TARGETED RADIOTHERAPY, A NEW CONCEPT IN THE TREATMENT OF ADVANCED-STAGE NEUROBLASTOMA
DEKRAKER, J
HOEFNAGEL, CA
CARON, H
OLMOS, RAV
ZSIROS, J
HEIJ, HA
VOUTE, PA
EUROPEAN JOURNAL OF CANCER, 1995, 31A (04) : 600 - 602

← 1 2 3 4 5 →